Balanced news tone
News Sentiment
HCM sentiment intelligence
HUTCHMED (China) Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-7.3% over one week, +0.0% over four weeks, trend inactive, and below fair value.
HUTCHMED (China) Ltd (HCM) Shares Surge 3.0% -- What GF Score of 79 Tells Investors
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
HUTCHMED (China) Ltd (HCM) Shares Surge 3.0% -- What GF Score of 79 Tells Investors
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 00:23
- Source
- GuruFocus
Analysts Have Conflicting Sentiments on These Healthcare Companies: HUTCHMED (HCM), Axsome Therapeutics (AXSM) and Vertex Pharmaceuticals (VRTX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 10:42
- Source
- The Globe and Mail
HUTCHMED Savolitinib China Approval Lifts HCM Shares 11.7%
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 04 Jul 2026 16:19
- Source
- Financial-News.co.uk
REG - Hutchmed China Ltd - HUTCHMED Announces NMPA Approval for ORPATHYS
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 02 Jul 2026 07:00
- Source
- TradingView
HUTCHMED (NASDAQ: HCM) schedules 2026 half-year results and investor webcasts
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
HUTCHMED to post half-year results July 30, with analyst webcasts
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
REG - Hutchmed China Ltd - Announcement on blocklisting six monthly return
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 08:30
- Source
- TradingView
HUTCHMED (HCM) details 2015 and 2026 share option blocklisting return
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Stock Titan
RCS - Hutchmed China Ltd - HUTCHMED Highlights Phase II Data at ESMO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- TradingView
HUTCHMED (China) Ltd (HCM) Shares Fall 3.5% -- What GF Score of 81 Tells Investors
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- GuruFocus
Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Market source
HCM City strengthens global capital links with London Stock Exchange partnership
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 14 Apr 2026 07:00
- Source
- vietnamnews.vn
Should You Be Adding HUTCHMED (China) (LON:HCM) To Your Watchlist Today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- Market source
HUTCHMED (China) Limited's (LON:HCM) largest shareholders are retail investors who were rewarded as market cap surged UK£189m last week
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jan 2026 08:00
- Source
- simplywall.st
HUTCHMED Establishes its International Research Centre at Hong Kong Science Park
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Aug 2024 07:00
- Source
- Hong Kong Science & Technology Parks Corporation
Hutchmed partner Inmagene exercises options over two drug candidates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2024 08:00
- Source
- Sharecast.com